Subclinical atherosclerosis as a risk factor of cardiovascular events

Subclinical atherosclerosis is an initial, latent stage of chronic progressing arterial inflammation. Destabilisation of asymptomatic, hemodynamically non-significant atherosclerotic plaques (AP) could lead to myocardial infarction, stroke, or sudden death. Since the assessment of AP stability is pr...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Boytsov, V. V. Kukharchuk, Yu. A. Karpov, I. V. Sergienko, O. M. Drapkina, A. E. Semenova, S. Zh. Urazalina
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2012-06-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1827
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250248626536448
author S. A. Boytsov
V. V. Kukharchuk
Yu. A. Karpov
I. V. Sergienko
O. M. Drapkina
A. E. Semenova
S. Zh. Urazalina
author_facet S. A. Boytsov
V. V. Kukharchuk
Yu. A. Karpov
I. V. Sergienko
O. M. Drapkina
A. E. Semenova
S. Zh. Urazalina
author_sort S. A. Boytsov
collection DOAJ
description Subclinical atherosclerosis is an initial, latent stage of chronic progressing arterial inflammation. Destabilisation of asymptomatic, hemodynamically non-significant atherosclerotic plaques (AP) could lead to myocardial infarction, stroke, or sudden death. Since the assessment of AP stability is problematic in real-world clinical settings, the risk stratification should, at least, account for the presence of subclinical atherosclerosis. In 600 ambulatory patients from the Moscow City Western Administrative Okrug who had low and moderate SCORE-assessed cardiovascular risk levels, the prevalence of AP, based on the duplex carotid ultrasound results, was 59% (n=358). Presently, no standard guidelines exist on cardiovascular risk stratification which would include the assessment of subclinical atherosclerosis, despite the importance of the latter as a prognostic factor. Large clinical studies on prognosis in patients with subclinical atherosclerosis will clarify the role of this parameter as an independent cardiovascular risk factor and facilitate the development of respective clinical recommendations.
format Article
id doaj-art-d165f5f6d5e648029aa4a35e04dfe50c
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2012-06-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-d165f5f6d5e648029aa4a35e04dfe50c2025-08-20T03:57:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252012-06-01113828610.15829/1728-8800-2012-3-82-861542Subclinical atherosclerosis as a risk factor of cardiovascular eventsS. A. Boytsov0V. V. Kukharchuk1Yu. A. Karpov2I. V. Sergienko3O. M. Drapkina4A. E. Semenova5S. Zh. Urazalina6Russian Cardiology Scientific and Clinical Complex, MoscowRussian Cardiology Scientific and Clinical Complex, MoscowRussian Cardiology Scientific and Clinical Complex, MoscowRussian Cardiology Scientific and Clinical Complex, MoscowRussian Cardiology Scientific and Clinical Complex, MoscowRussian Cardiology Scientific and Clinical Complex, MoscowRussian Cardiology Scientific and Clinical Complex, MoscowSubclinical atherosclerosis is an initial, latent stage of chronic progressing arterial inflammation. Destabilisation of asymptomatic, hemodynamically non-significant atherosclerotic plaques (AP) could lead to myocardial infarction, stroke, or sudden death. Since the assessment of AP stability is problematic in real-world clinical settings, the risk stratification should, at least, account for the presence of subclinical atherosclerosis. In 600 ambulatory patients from the Moscow City Western Administrative Okrug who had low and moderate SCORE-assessed cardiovascular risk levels, the prevalence of AP, based on the duplex carotid ultrasound results, was 59% (n=358). Presently, no standard guidelines exist on cardiovascular risk stratification which would include the assessment of subclinical atherosclerosis, despite the importance of the latter as a prognostic factor. Large clinical studies on prognosis in patients with subclinical atherosclerosis will clarify the role of this parameter as an independent cardiovascular risk factor and facilitate the development of respective clinical recommendations.https://cardiovascular.elpub.ru/jour/article/view/1827atherosclerosisatherosclerotic plaquecardiovascular risk
spellingShingle S. A. Boytsov
V. V. Kukharchuk
Yu. A. Karpov
I. V. Sergienko
O. M. Drapkina
A. E. Semenova
S. Zh. Urazalina
Subclinical atherosclerosis as a risk factor of cardiovascular events
Кардиоваскулярная терапия и профилактика
atherosclerosis
atherosclerotic plaque
cardiovascular risk
title Subclinical atherosclerosis as a risk factor of cardiovascular events
title_full Subclinical atherosclerosis as a risk factor of cardiovascular events
title_fullStr Subclinical atherosclerosis as a risk factor of cardiovascular events
title_full_unstemmed Subclinical atherosclerosis as a risk factor of cardiovascular events
title_short Subclinical atherosclerosis as a risk factor of cardiovascular events
title_sort subclinical atherosclerosis as a risk factor of cardiovascular events
topic atherosclerosis
atherosclerotic plaque
cardiovascular risk
url https://cardiovascular.elpub.ru/jour/article/view/1827
work_keys_str_mv AT saboytsov subclinicalatherosclerosisasariskfactorofcardiovascularevents
AT vvkukharchuk subclinicalatherosclerosisasariskfactorofcardiovascularevents
AT yuakarpov subclinicalatherosclerosisasariskfactorofcardiovascularevents
AT ivsergienko subclinicalatherosclerosisasariskfactorofcardiovascularevents
AT omdrapkina subclinicalatherosclerosisasariskfactorofcardiovascularevents
AT aesemenova subclinicalatherosclerosisasariskfactorofcardiovascularevents
AT szhurazalina subclinicalatherosclerosisasariskfactorofcardiovascularevents